UCI Co.,Ltd. (KOSDAQ:A038340) acquired 30.9% stake in Bio X Co., Ltd. from group of sellers for KRW 20 billion on March 3, 2020. As per the transaction, UCI Co.,Ltd. was to acquire 0.66 million shares. As of September 30, 2019, Bio X Co., Ltd. has reported total assets of 60.6 billion and total debt of KRW 17.2 billion. The Board passed the resolution for the transaction. Scheduled completion date is March 3, 2020.

UCI Co.,Ltd. (KOSDAQ:A038340) completed the acquisition of 30.9% stake in Bio X Co., Ltd. from group of sellers on March 3, 2020.